Figure 7.
Figure 7. Expression of sialyl 6-sulfo Lex and related determinants on ConA- or TPA-treated human peripheral lymphocytes. Human peripheral lymphocytes were stimulated with 10 ng/mL TPA and 1 μg/mL ionomycin (middle panel) or with 5 μg/mL ConA (right panel) for 1 or 3 days. Each panel indicates 2-dimensional distribution of sialyl 6-sulfo Lex (G152), conventional sialyl Lex (CXLEX-1), CLA (HECA-452), and variant sialyl Lex (2F3) with CD3.

Expression of sialyl 6-sulfo Lex and related determinants on ConA- or TPA-treated human peripheral lymphocytes. Human peripheral lymphocytes were stimulated with 10 ng/mL TPA and 1 μg/mL ionomycin (middle panel) or with 5 μg/mL ConA (right panel) for 1 or 3 days. Each panel indicates 2-dimensional distribution of sialyl 6-sulfo Lex (G152), conventional sialyl Lex (CXLEX-1), CLA (HECA-452), and variant sialyl Lex (2F3) with CD3.

Close Modal

or Create an Account

Close Modal
Close Modal